 ventricular tachycardia sarcoidosis assessment underlying cardiac anatomy prospective utility programmed ventricular stimulation drug therapy implantable antitachycardia device presentation cardiac anatomy utility programmed ventricular stimulation patients sustained ventricular tachycardia sarcoidosis mean patient age years Pulmonary involvement apparent patients systemic manifestations sarcoidosis present patient patients electrocardiographic abnormalities rest left ventricular ejection fraction patients ventricular wall motion abnormalities mitral valve dysfunction ventricular tachycardia patients Spontaneous ventricular tachycardia corticosteroid administration antiarrhythmic drug therapy patients sudden cardiac death additional recurrence ventricular tachycardia patients automatic cardioverter-defibrillator implanted received drug therapy appropriate shocks report descriptive series consecutive patients sustained ventricular tachycardia sarcoidosis Antiarrhythmic drug therapy ventricular tachycardia patients sarcoidosis programmed ventricular stimulation high rate arrhythmia recurrence sudden death implantation automatic antitachycardia device cardioverter-defibrillator primary therapy patients Furthermore sarcoidosis Kveim necessary patient sustained ventricular tachycardia unknown origin